Concepedia
Statistics
Publications
23
Citations
3.4K
H-Index
20
Active since
1990
Affiliations
Yale University(Current)
Sanofi (United States)
Sanofi (France)
VaxInnate (United States)
Fundação Oswaldo Cruz
James W. Huleatt is an author at Yale University specializing in life sciences, immunology, and infectious diseases.
Publications per year
1990–2023
Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled Antigen
Stephanie C. Eisenbarth, Damani A. Piggott, James W. Huleatt et al. · The Journal of Experimental Medicine · 2002 · 1.2K citations · Full text
Life Sciences, Immunology, Allergy +16
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin
James W. Huleatt, Valerian Nakaar, Priyanka Desai et al. · Vaccine · 2007 · 386 citations
Life Sciences, Immunology, Infectious Diseases +17
Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity
James W. Huleatt, Andrea R. Jacobs, Jie Tang et al. · Vaccine · 2006 · 296 citations
Life Sciences, Immunology, Immunization +13
MyD88-dependent induction of allergic Th2 responses to intranasal antigen
Damani A. Piggott, Stephanie C. Eisenbarth, Lan Xu et al. · Journal of Clinical Investigation · 2005 · 211 citations · Full text
Life Sciences, Immunology, Adaptive Immunity +16
Damani A. Piggott, Stephanie C. Eisenbarth, Lan Xu et al. · Journal of Clinical Investigation · 2005 · 205 citations · Full text
1–5 of 23